Digital health and AI empower patients and physicians toward longevity
Artificial intelligence and digital health are playing transformative roles in the way health care is delivered in Abu Dhabi while improving patient care. And as the UAE capital puts itself front and centre of this digital age revolution, Abu Dhabi Global Health Week has again placed that progress in the spotlight. On the sidelines of the second health week, Ibrahim Al Jallaf, executive director of digital health at the Department of Health Abu Dhabi, revealed how Abu Dhabi's embracing of and taking forward the potential impact of AI and digital health was already bringing results. He defined digital health as the application of digital analytics and AI into the healthcare space and said it should complement and build 'on top of the existing system'. While AI is potentially impacting almost every aspect of human life, Mr Al Jallaf said that within the healthcare segment is where the effects could perhaps be felt most potently. 'AI has been there for quite a few years. However, more recently it's spiked in terms of prevalence and use, and that's the real game changer,' he told The National. 'The question that we're being asked quite a bit is how can AI positively impact healthcare. And the biggest benefit we're seeing is on enabling the shift from healthcare to health; how do we improve the healthy average life expectancy of the population?' 'Now, with artificial intelligence, we're starting to see a lot of solutions drive towards that, which is very impactful.' Mr Al Jallaf explained that everything done in digital health anchors on pillars such as whether it will drive a healthy population and improve healthy average life expectancy, improve accessibility or quality of care, and drive a resilient, innovative healthcare system that can handle future shocks, such as Covid, alongside long-term healthcare system sustainability. 'We look globally for advancements, and over the past few years, AI has become a lot more relevant,' he said. 'So where we find success cases and potential for innovation, we bring them to the UAE, and we grow some of them out of the UAE to then drive a healthier population.' Some innovations are experienced daily, while the impact of medical advances may be seen in the long term with better life quality and expectancy. 'The advantage of digital products and artificial intelligence, typically, is in scaling,' Mr Al Jallaf said. 'The opportunity to scale to millions, population-wide, and have scaled impact is where digital products and AI really kicks into gear and becomes extremely powerful. Our priority is the population, and the way to benefit the entire population is through these channels.' He gives the Sahatna app - 'our gateway to health' - as an example, as every Abu Dhabi individual has access. During Abu Dhabi Global Health Week, the DoH revealed Sahatna AI. 'It's a large language model with medical guardrails, fine-tuned for medical responses. It's all in-country, dealt with at the highest levels of patient privacy…connected to Malaffi, your health information exchange, and you can ask anything.' A user can, for example, check what medication they have been prescribed and why, simplifying the process of understanding. 'One of the things in Sahatna we're very passionate about is building out a significant wellness module, with the objective of improving the healthy average life expectancy,' Mr Al Jallaf continued. 'The focus is on the next best action for you as an individual to extend your lifespan. This really becomes your tailored health guide. And we don't just leave it at the patient level. We want to complement the ecosystem.' 'It's brilliant that the population is able to see this - giving a bit more control and oversight over their health care is important.' He explained that Malaffi is connected to all hospitals and clinics, so they all have 360-degree patient health records. 'They can ensure that they take the best care of you…that's incredible impact in action. Now, your physician and you both have the same 360-degree record, giving the patient more control, but also empowering the physician. This connected ecosystem has enabled us to do so much more.' This also better optimises the use of time and resources and can give a patient answers about a health issue without necessarily leaving home for a clinic waiting room, thereby improving care accessibility. 'How do you optimise population and patient experience? This is what we're seeing. And the benefits only increase from here,' said Mr Al Jallaf, expanding on how AI and digital fit in. 'It's a lot of AI-assisted care. We've rolled out numerous AI use cases and digital products to physicians. ' 'We have the patient risk profile, over 14 AI risk models. Each covers the probability of an individual getting a condition, such as diabetes or breast cancer, all based on their entire medical health record. 'In the AI models, there is explainability; if the physician clicks on it, they can see the different visits and lab test results this patient went through and they can then incorporate that into their care plans. 'This is live across 100 per cent of hospitals and clinics in Abu Dhabi, with over 70 per cent of physicians as active users. This is impact…and we're seeing a lot of success cases.' Some of the consequences of earlier work in the digital space are also being felt. Mr Al Jallaf said it will become more 'exponentially evident' but that health officials were already seeing positive changes in population health metrics and quality of care. 'Now the question is, how much further? The Department of Health will always strive to push the bar; the reality is, this is people's health care…the bar is always higher. There is no 'good enough' healthy average life expectancy, no 'good enough' quality of care, so we consistently strive to push the bar.' 'The obsession we have is, how do you drive the right impact? This is where we search the world for impact cases, because we're obsessed with success. 'We want to make sure all the initiatives and projects we do drive an increase in healthy average life expectancy, an increase in best class care, so we have conversations based on what's been successful and what we could do successfully. Which set of projects can we do to drive the highest impact?' Hosting an event such as Abu Dhabi Global Health Week enables collaboration and information sharing to take the broader health agenda forward, said Mr Al Jallaf. 'We consider ourselves one of the globally leading governments in health tech. There are other global health leaders that inspire us, and we leverage opportunities such as Abu Dhabi Global Health Week to spark these conversations. 'The fact that we have some great examples of impact puts us on the table to spark even greater conversations, because they see inspirational stories come out of us, and they bring their own inspirational stories. 'So we're now having conversations that are incredibly impactful because some other global leaders are excited to have a conversation with us, which only sparks further innovation. 'We're constantly looking for the next best innovation to move the needle on.' Mr Al Jallaf said that Abu Dhabi Global Health Week also gave exposure to new apps, AI use cases, and concepts that can be related to the UAE. 'The global perspective from leading AI experts is that healthcare is one of the fundamental sectors that will experience a significant amount of benefit from AI,' he added. 'The level of conversation and the excitement I hear from different leaders in healthcare is very strong. When you tell a leading health expert that they can improve the lives of a million people, the inspiration and the excitement are unlimited.' This page was produced by The National in partnership with Abu Dhabi Global Health Week.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TECHx
a day ago
- TECHx
Abu Dhabi, Abbott Partner to Boost Local Pharma Sector
Home » Smart Sectors » Healthcare » Abu Dhabi, Abbott Partner to Boost Local Pharma Sector The Department of Health, Abu Dhabi (DoH), the healthcare sector regulator in Abu Dhabi, announced a strategic partnership with global healthcare leader Abbott. The agreement was signed during the BIO International Convention held in Boston, USA. The partnership aims to localise pharmaceutical manufacturing in Abu Dhabi. It also focuses on advancing digital health solutions across the emirate. Officials revealed that the collaboration builds on Abu Dhabi's advanced life sciences infrastructure. This move supports the emirate's goal to reduce dependency on imports and strengthen supply chain resilience. It further reflects Abu Dhabi's commitment to fostering a self-sufficient and sustainable healthcare ecosystem. Dr. Noura Al Ghaithi, Undersecretary of DoH, stated that the partnership follows the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi. She added that the emirate is equipped with an integrated infrastructure to support local manufacturing and R&D. She said the agreement would position Abu Dhabi as a regional healthcare hub and leader in life sciences. According to her, aligning DoH's strategic vision with Abbott's global expertise will accelerate the delivery of innovative healthcare products and solutions. The collaboration is built around four key pillars: Localising Abbott's pharmaceutical portfolio and developing biosimilars. Advancing digital transformation through electronic patient information leaflets. Launching education programs to strengthen the healthcare workforce. Supporting regulatory alignment and joint R&D initiatives. Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant, reported that this partnership will enhance healthcare resilience and innovation in Abu Dhabi. He highlighted Abbott's ongoing commitment to the UAE's healthcare system. He noted that the partnership will also include digitising life sciences product information and launching training initiatives to build local capabilities. In addition, both parties will explore opportunities for joint research and development. DoH also reported that a high-level delegation has embarked on a strategic mission to the United States from 15 to 21 June 2025. The delegation will conduct over 20 meetings with public and private sector leaders. These meetings aim to promote knowledge exchange, attract investments, and sign new agreements that accelerate advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes: Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, and PureHealth. Etihad Cargo, New York University Abu Dhabi, Khalifa University, startAD, and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI). This announcement highlights Abu Dhabi's global ambitions in life sciences and healthcare innovation.
Filipino Times
a day ago
- Filipino Times
Abu Dhabi launches personalized weight loss programme; first in the Middle East
Abu Dhabi has launched the region's first Personalised Weight Management Programme to help residents manage their weight and prevent serious health problems. The program aims to lower the risk of diseases like type 2 diabetes, heart problems, and some cancers, improving the quality of life and helping people live longer, Abu Dhabi Media Office reported. An initiative of the Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC), this is the first program of its kind in the Middle East that combines online health tracking, insurance support, and medical care tailored to each person. 'Our focus is on health – not just weight. This programme supports our vision for an active, health-conscious community, empowering individuals through personalised and science-driven solutions,' Dr. Noura Al Ghaithi, Undersecretary of DoH, said. Those eligible include Thiqa insurance members aged 18 and above who are medically classified as overweight or obese. The plan includes early health checks, one-on-one coaching, diet and exercise guidance, and check-ups using the Sahatna health app.
Al Etihad
2 days ago
- Al Etihad
DoH, Abbott unite to manufacture pharmaceuticals locally in Abu Dhabi
20 June 2025 22:37 BOSTON (WAM) Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Abbott, the global healthcare leader, entered a landmark partnership during the BIO International Convention in Boston agreement aims to localise the manufacturing of pharmaceuticals in Abu Dhabi and advance digital health Abu Dhabi's advanced life sciences infrastructure, this milestone reflects the emirate's proactive preparedness to reduce dependency on imports, strengthen supply chain resilience, and foster a sustainable, self-sufficient healthcare Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said, 'Following the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi, the emirate proved to be equipped with a holistic, integrated infrastructure that fosters local manufacturing and R&D, positioning it as a regional healthcare gateway and leader in life sciences." She added, "By integrating our strategic vision with Abbott's expertise, we aim to accelerate the development and deployment of innovative healthcare products and solutions, reducing time-to-market, improving healthcare outcomes, and ensuring that breakthrough therapies reach patients faster. This approach positions Abu Dhabi as a regional leader in fostering an agile, innovation-driven healthcare ecosystem that directly translates scientific advancements into tangible benefits for our community.'The strategic collaboration outlines a comprehensive plan focusing on four key pillars including localisation of Abbott's pharmaceutical portfolio, biosimilar development, digital transformation through electronic patient information leaflets, and a robust education and workforce development his part, Mazen Bachir, Regional Director for Abbott's established pharmaceuticals business in the Gulf, Emerging Markets and Levant, said, 'Abbott is proud to announce a strategic collaboration with the Department of Health – Abu Dhabi, aimed at advancing healthcare resilience and innovation in Abu Dhabi." Bachir added, "Building on Abbott's long-standing commitment to the UAE's healthcare system, this partnership will focus on localising existing pharmaceutical products, and jointly exploring the development of biosimilars, supported by regulatory alignment. The collaboration also includes initiatives to digitise life science product information through electronic leaflets in alignment with the UAE's digital health strategy. Another key component of this collaboration is the development of education programs to build local capabilities. Additionally, Abbott and the Department of Health will evaluate opportunities for joint research and development to strengthen long-term healthcare sustainability in the UAE.'Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 - 21, 2025. The delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the US, aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI).
